Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yangxindingji capsule for premature ventricular contractions (with or without bradyarrhythmia)
ChiCTR2400087963Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Henan University of Chinese Medicine
- Start
- Aug 2024
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Yangxindingji capsule in Premature ventricular complexes (PVC), bradyarrhythmia and heart palpitations (2 arms), sponsored by First Affiliated Hospital of Henan University of Chinese Medicine. Primary endpoint: 24-hour Holter monitor at 12 weeks. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
Yangxindingji capsule
03
Conditions
Premature ventricular complexes (PVC)bradyarrhythmiaheart palpitations
Beyond the preview
Go deeper on ChiCTR2400087963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400087963.